Initial platelet activity may predict efficacy after chronic oral glycoprotein IIb/IIIa blockade: Should we still consider uniform treatment regimens?

Paul A. Gurbel, Marcus E. McKenzie, Victor L. Serebruany

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)105-107
Number of pages3
JournalThrombosis research
Issue number1
StatePublished - Jul 1 2000


  • Coronary artery disease
  • Efficacy
  • Oral GPIIb/IIIa inhibitors
  • Platelets

ASJC Scopus subject areas

  • Hematology

Cite this